" The company(Royce Pharma) generated a revenue of RM24.133 million in the financial year ended Dec 31, 2018, but posted a loss before tax of RM431,081 and loss after tax of RM682,653. Retained losses stood at RM2.596 million.
It remains to be seen how Ta Win will fund the acquisition of Royce Pharma, given its net debt position of RM13.2 million as at Sept 30."
wth this small company developing 2.4b terrenganu ecopark, acquire sin line tek ,royce pharma.. A market cap 100m company, so they going right issue another 100 mil to support the acquisition? And they are also in debt position. I will wait how much money they propose for the right issue first.I estimate 100m to be raised.
5.3 Financial and Operating Policies of Royce Pharma
Ta Win will not have the control to govern the financial and operating policies of Royce Pharma as Royce Pharma will only be a 32.5%-owned associate company of Ta Win (held through TWC Biohealth) upon the completion of the Proposed Investment. As such, there is a possibility that Royce Pharma’s future business plans/direction may not be aligned with Ta Win’s investment objectives.
To mitigate this risk, Ta Win is entitled to appoint 2 representatives on the board of directors of Royce Pharma to ensure that Ta Win in keeping abreast with Royce Pharma’s business development, deliberate on its key policies/strategies and to safeguard the Group’s interest in Royce Pharma.
The actual proceeds (in excess of the Minimum Subscription Level) that may be raised from the Proposed Rights Issue will depend on the total number of issued Shares as at the Entitlement Date and the actual subscription rate of the Proposed Rights Issue.
*Excess amount RM175.6 million
Under the Minimum Scenario, the Ta Win Group intends to utilise RM5.0 million to part finance the preliminary cost required for the development of the Terengganu Ecocycle Park’s core technology zone measuring approximately 85 acres. The preliminary cost is budgeted to be approximately RM57.3 million for the lease payment and the other incidental cost such as application costs for the development order and other statutory approvals for the Land.
Under the Maximum Scenario, the Ta Win Group intends to utilise up to RM90.0 million to part finance the preliminary and construction costs required for the development of the Terengganu Ecocycle Park’s core technology zone. Based on the Group’s management’s estimates, the total preliminary and construction costs for the Terengganu Ecocycle Park’s core technology zone is approximately RM57.3 million and RM521.2 million (including the construction cost for Ta Win’s new main office and factories of RM360.0 million) respectively. Any surplus/shortfall arising from the utilisation of the preliminary cost will be adjusted to/from the construction cost allocated for the development of the Terengganu Ecocycle Park’s core technology zone.
The shortfall in financing the aforementioned total preliminary and construction costs will be funded via the Group’s internally generated funds, bank borrowings and/or other funding alternatives such as equity fund-raising exercises to be undertaken by the Company. However, in the event that the Proposed Joint Venture is not completed for any reason, the allocation earmarked for the development cost of Terengganu Ecocycle Park will be utilised for the Group’s working capital purposes.
On behalf of the Board, Mercury Securities wishes to announce that Ta Win had on 23 December 2020 entered into the following:
(i) a second supplemental letter to the SSA with the Vendor to further extend the stipulated period for the fulfilment of conditions precedent of the SSA to 23 February 2021;
(ii) a second supplemental letter to the Subscription Agreement with the Vendor and Sin Line Tek to further extend the stipulated period for the fulfilment of conditions precedent of the Subscription Agreement to 23 February 2021; and
(iii) a second supplemental letter to the Shareholders Agreement with the Vendor and Lim Wai Keong (the other shareholder of Sin Line Tek) to further extend the stipulated period for the fulfilment of conditions precedent of the Shareholders Agreement to 8 March 2021.
KUALA LUMPUR: Copper products maker Ta Win Holdings Bhd’s healthcare subsidiary, Ta Win Copper Biohealth Sdn Bhd (TWCB), has completed the acquisition of a 32.5 per cent equity interest stake in Royce Pharma Manufacturing Sdn Bhd for RM20.85 million.
In a statement today, Ta Win group managing director Datuk Seri Ngu Tieng Ung said the acquisition would enable the group to capitalise on Royce Pharma’s robust pharmaceutical capabilities and experience.
"As our first foray into the pharmaceutical industry, which holds vast prospects, this positions us well to leverage on Royce Pharma’s expertise and strong track record in the sector.
"Building on this, we are confident that this will contribute to the group's performance moving forward," he said.
Ngu said following this acquisition, the group aimed to tap into viable opportunities, including the development of pharmaceutical products that meet evolving global healthcare needs, particularly during the COVID-19 pandemic.
"We will continue to look into downstream applications of the biochemistry and chemistry of copper and copper proteins to further strengthen our prospects over the long term,” he added.
The acquisition was concluded in accordance with the terms and conditions of the share sale agreement (SSA) and subscription agreement.
The profit guarantee agreement and shareholders agreement have also become unconditional effective today. - Bernama
TAGS: Ta Win Copper Biohealth Sdn Bhd, Ta Win, Ngu Tieng Ung, Acquisition, Royce Pharma
My chart analysis expecting tawin to fly tomorrow, but the main condition must be fulfilled which is the market trend must still siding on industrial. Macd about to cross, rsi already did and the ema is going high seems to be
tP i guess is not just 0.30 ....base on other stock's post covid trend, shareholders will compensation their loss of income from equity market .....jack up high for funding ....it might at least 50-60 cts or even higher ..but no body will know ...but price fluctuation is very high ..BEWARE!!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
YYhappy
3 posts
Posted by YYhappy > 2020-12-23 16:18 | Report Abuse
0.205 d.. Tawin bound back.. today will closed 0.225